Chai Discovery

Series C · SF Bay Area

Design suite for molecules

Chai Discovery builds a design suite for molecules, training frontier models that learn the underlying rules of biochemical structure and interaction. The point is reach as much as speed: scientists can pursue targets that other computational methods cannot get to. Leading pharmaceutical companies including Eli Lilly, Pfizer and Novartis run the platform inside their drug discovery programmes. The team works at high velocity with individual ownership over the work.

Last round

$400MSeries CJul 2026led by Index Ventures

3open rolesProduct, GTM, Sales, Marketing, BizOps, Data, and Chief of Staff

RoleEst. Compensation

Research ScientistChai DiscoveryML/AI Research · IC · Series C · On-site · SF Bay Area

—

Data OpsChai DiscoveryBusiness Operations · IC · Series C · On-site · SF Bay Area

—

Business Development